Cassava Sciences | PTIE - Loan Capital

Stock Price
2.27
Daily Change
-0.08 -3.40%
Monthly
11.27%
Yearly
-5.42%
Q1 Forecast
2.06

Cassava Sciences reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Amgen USD 50B 2.43B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 134.77B 12M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Geron USD 119.26M 273K Sep/2025
J&J USD 39.44B 30M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Novavax USD 223.63M 187K Sep/2024
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025